Moody Aldrich Partners LLC Has $4.66 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Moody Aldrich Partners LLC trimmed its position in HealthEquity, Inc. (NASDAQ:HQY) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,895 shares of the company’s stock after selling 1,151 shares during the quarter. Moody Aldrich Partners LLC’s holdings in HealthEquity were worth $4,657,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Private Advisor Group LLC bought a new position in shares of HealthEquity during the 3rd quarter valued at about $208,000. Sequoia Financial Advisors LLC raised its stake in shares of HealthEquity by 2.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,314 shares of the company’s stock worth $1,090,000 after purchasing an additional 303 shares in the last quarter. Raymond James & Associates raised its stake in shares of HealthEquity by 1.3% during the 3rd quarter. Raymond James & Associates now owns 151,318 shares of the company’s stock worth $12,385,000 after purchasing an additional 1,911 shares in the last quarter. AlphaMark Advisors LLC raised its stake in shares of HealthEquity by 18.8% during the 3rd quarter. AlphaMark Advisors LLC now owns 4,570 shares of the company’s stock worth $374,000 after purchasing an additional 722 shares in the last quarter. Finally, Creative Planning increased its holdings in shares of HealthEquity by 18.6% in the third quarter. Creative Planning now owns 23,632 shares of the company’s stock valued at $1,934,000 after purchasing an additional 3,706 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In related news, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the sale, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $0.17 during mid-day trading on Thursday, reaching $87.78. 29,984 shares of the company’s stock were exchanged, compared to its average volume of 609,156. The firm has a market capitalization of $7.64 billion, a price-to-earnings ratio of 95.23, a price-to-earnings-growth ratio of 1.31 and a beta of 0.52. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $89.23. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The firm has a 50-day moving average price of $79.77 and a two-hundred day moving average price of $79.62.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The company had revenue of $299.93 million for the quarter, compared to analysts’ expectations of $284.48 million. Analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on HQY shares. Barrington Research reissued an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Bank of America decreased their price target on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, JMP Securities restated a “market outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $103.83.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.